A descriptive retrospective study into pharmacy led paediatric commissioning services when processing individual funding requests for PCTs

Ubhi, H. K.; Terry, D. R. P.
April 2011
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Apr2011, Vol. 96 Issue 4, pe1
Academic Journal
Objective To quantify the success of a Pharmacist led paediatric commissioning service in securing individual funding requests (IFR) to Primary Care Trusts (PCTs). Methods Descriptive, retrospective study over a 4 month period by review of IFR sent to PCTs. The IFRs were completed by the lead clinician with support from the commissioning lead pharmacist. Inclusion criteria included (1) Patient's who's treatment falls outside existing service agreements with clear evidence of clinical effectiveness for the therapy applied for. (2) Where patient was considered exceptional, in that clinical features of the patient made them significantly different to that described within existing commissioning agreements and where the patient would gain an enhanced clinical benefit from the requested intervention, than might normally be expected in the general population. The IFR was sent to relevant patient's PCT. Responses from PCTs were via email and letter and then forwarded to the patient's clinicians. Data was entered into MS Excel 2003 for analysis and included, patient demographics, clinical categories, amount of funding, details of follow-up phone calls to PCTs. Information was sent to the finance department, so treatment costs were reclaimed. If declined, this was logged with reasons so to modify future applications and inform clinical decision making. Results Responses relating to 15 IFRs, to 10 different PCTs across the country with each PCT receiving 1 or more request (n=1-2). Six specialities, gastroenterology 53.3% (n=8), haematology 13.3% (n=2), respiratory 13.3% (n=2), neurology 6.6% (n=1), rheumatology 6.6% (n=1) and ophthalmology 6.6% (n=1) had made IFR requests during the study period. 73% (n=11) had funding approved, 20% (n= 3) were declined and 7% (n=1) for which a response is still awaited. Of the three declined, there were two cases where the PCT had refused due to the request being retrospective and the other case was determined not to meet criteria as an exceptional case. We received seven responses within 3 weeks, with 53.3% (n=8) of the cases having to be chased on at least one occasion. In monetary terms, a projected benefit of £459k was made as a result of the Pharmacy commissioning service from the 11 approved cases although further work will be required to identify and difference to conventional commissioning arrangements. Conclusion The pharmacy led paediatric drug commissioning service is highly successful with a 73% success rate and recovering IFR related monies per annum of approximately £459k for the 11 approved cases, with a potential annual value of £1.37M on the basis of the same kind of claims each quarter.


Related Articles

  • An evaluation of clinical pharmacist contributions in paediatrics. McArtney, R. J.; McArtney, R. G.; Postle, J. A.; Williams, R. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Apr2011, Vol. 96 Issue 4, pe1 

    Objective To collect clinical pharmacists interventions to profile pharmacy services, evaluate training needs and support business planning for the service; to classify these interventions by severity and stage of medication use process; and to demonstrate the financial value of pharmacists...

  • PICU pharmacist interventions: what can they tell us? Isaac, R.; Gerrard, A. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Apr2011, Vol. 96 Issue 4, pe1 

    Objective The Pharmacy Paediatric Intensive Care (PICU) team record interventions that affect a patient's episode on PICU. These interventions are not always reported via the hospital's incident reporting route. The aim of this report is to highlight information that may benefit or influence a...

  • Clinical trials of medicines in children. Choonara, Imti // BMJ: British Medical Journal (International Edition);11/04/2000, Vol. 321 Issue 7269, p1093 

    Editorial. Focuses on the lack of scientific data related to the use of medicines in children. Reluctance of the pharmaceutical industry to conduct clinical trials of medicines in children; Efforts of the United States Food and Drug Administration (FDA) to encourage such studies; Practical...

  • What do you do when you don't have a diagnosis?  // British Columbia Medical Journal;May2012, Vol. 54 Issue 4, p193 

    The article focuses on the study launched by researchers at the University of British Columbia and the University of Calgary which will explore uncertainty in medical diagnosis.

  • Development of a single paediatric infliximab administration guideline. Kasuji, S.; Wood, M.; Lilley, R.; Collins, S. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Apr2011, Vol. 96 Issue 4, pe1 

    Objective Three separate infliximab prescribing and administration guidelines were being used within the paediatric departments at LTHT. Over a 6 month period this caused selection errors which resulted in a number of administration rate errors. The aim of this project was to develop a single...

  • Pharmacy on wheels: bringing pharmaceutical care to the childs bedside. Naeem, Q.; Tomlin, S.; Thornhill, W.; Hayes, P. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Apr2011, Vol. 96 Issue 4, pe1 

    Objectives The ward based satellite pharmacies at the Evelina Children's hospital, based in the main drug room on the ward, were designed to supply one-stop-medicines on a daily basis to children's electronically controlled bedside lockers. Utilisation of this room caused interruptions to nurses...

  • Perforated left-sided diverticulitis with faecal peritonitis: is the Hinchey classification the best guide for surgical decision making? Naraynsingh, V.; Maharaj, R.; Hassranah, D.; Hariharan, S.; Dan, D.; Zbar, A. P. // Techniques in Coloproctology;Jun2011, Vol. 15 Issue 2, p199 

    Background: Although the Hinchey scoring system has guided surgical decision making for perforated diverticulitis, what constitutes optimal surgical management is controversial. We report our experience of selective primary closure of the perforation without use of a transverse colostomy and the...

  • Comparative evaluation of midazolam and butorphanol as oral premedication in pediatric patients. Sinha, Chandni; Kaur, Manpreet; Kumar, Ajeet; Kulkarni, Anand; M., Ambareesha; Upadya, Madhusudan // Journal of Anaesthesiology Clinical Pharmacology;Jan2012, Vol. 28 Issue 1, p32 

    Background: To compare oral midazolam (0.5 mg/kg) with oral butorphanol (0.2 mg/kg) as a premedication in 60 pediatric patients with regards to sedation, anxiolysis, rescue analgesic requirement, and recovery profile. Materials and Methods: In a double blinded study design, 60 pediatric patients...

  • Drug utilisation profile in the Italian paediatric population. Clavenna, Antonio; Berti, Alessandra; Gualandi, Lucia; Rossi, Elisa; De Rosa, Marisa; Bonati, Maurizio // European Journal of Pediatrics;Feb2009, Vol. 168 Issue 2, p173 

    Objective: In order to evaluate the prescribing pattern in the Italian paediatric population, prescriptions involving 923,353 children under 14 years old and dispensed during 2006 by the retail pharmacies of 22 Italian local health units were analysed.Materials and Methods:...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics